These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9123116)

  • 1. Causes of graft loss following liver transplantation for chronic hepatitis C.
    O'Reilly PM; Rosen HR; Shackleton CR; McDiarmid S; Holt C; Busuttil RW; Martin P
    Transplant Proc; 1997; 29(1-2):526-8. PubMed ID: 9123116
    [No Abstract]   [Full Text] [Related]  

  • 2. Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.
    Platz KP; Mueller AR; Willimski C; Mansoorian B; Berg T; Neuhaus R; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1468-9. PubMed ID: 9636596
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract]   [Full Text] [Related]  

  • 4. Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation.
    Platz KP; Mueller AR; Willimski C; Mansoorian B; Berg T; Neuhaus R; Hopf U; Radke C; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):2232-3. PubMed ID: 9723453
    [No Abstract]   [Full Text] [Related]  

  • 5. Indications for determination of alpha-glutathione-s-transferase after liver transplantation.
    Platz KP; Mueller AR; Müller C; Wenig M; Schumacher G; Steinmüller T; Köttgen E; Neuhaus P
    Transplant Proc; 1999; 31(1-2):462-4. PubMed ID: 10083191
    [No Abstract]   [Full Text] [Related]  

  • 6. High-rate hepatitis and low-rate rejection induced late morbidity and mortality in long-term follow-up after liver transplantation.
    Caccamo L; Rossi G; Gridelli B; Maggi U; Reggiani P; Colledan M; Fassati LR
    Transplant Proc; 1998 Aug; 30(5):1828-9. PubMed ID: 9723298
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrence of hepatitis C after liver transplantation: follow-up and treatment.
    Dumortier J; Scoazec JY; Berger F; Boillot O
    Transplant Proc; 2002 May; 34(3):779-81. PubMed ID: 12034181
    [No Abstract]   [Full Text] [Related]  

  • 8. Is the use of marginal liver grafts justified?
    Mueller AR; Platz KP; Krause P; Steinmüller T; Glanemann M; Neumann U; Lobeck H; Neuhaus P
    Transplant Proc; 1999; 31(1-2):401-2. PubMed ID: 10083160
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term follow-up in hepatitis C patients with respect to immunosuppression.
    Mueller AR; Platz KP; Berg T; Fukomoto T; Guckelberger O; Neuhaus R; Bechstein WO; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3241-2. PubMed ID: 8962255
    [No Abstract]   [Full Text] [Related]  

  • 10. A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
    Fischer L; Sterneck M; Gahlemann CG; Malago M; Rogiers X; Broelsch CE
    Transplant Proc; 2000 Nov; 32(7):2125-7. PubMed ID: 11120098
    [No Abstract]   [Full Text] [Related]  

  • 11. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
    Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW
    Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of steroids amount on hepatitis C recurrence following orthtopic liver transplantation.
    Tisone G; Laria G; Orlando G; Pisani F; Palmieri GP; Bellanova G; Torri E; Buonomo O; Angelico M; Casciani CU
    Transplant Proc; 1999 Dec; 31(8):3167-8. PubMed ID: 10616427
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience with neoral cyclosporine through the oral route in liver transplantation.
    Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C
    Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation.
    Zervos XA; Weppler D; Fragulidis GP; Torres MB; Nery JR; Khan MF; Pinna AD; Kato T; Miller J; Reddy KR; Tzakis AG
    Transplantation; 1998 Apr; 65(8):1044-6. PubMed ID: 9583863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation: changing goals in immunosuppression.
    McMaster P; Gunson B; Min X; Afonso R; Bastos J
    Transplant Proc; 1998 Aug; 30(5):1819-21. PubMed ID: 9723295
    [No Abstract]   [Full Text] [Related]  

  • 16. Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation.
    Bronsther O; Mañez R; Kusne S; Irish W; Roland W; Jain A; Llull R; Demetris AJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):1206-7. PubMed ID: 7878851
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of crossmatch in liver transplantation.
    Gugenheim J; Baldini E; Pommier Bernard G; Goubaux B; Mouiel J
    Transplant Proc; 1999; 31(1-2):552-3. PubMed ID: 10083233
    [No Abstract]   [Full Text] [Related]  

  • 18. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
    Platz KP; Mueller AR; Neuhaus R; Keck HH; Lobeck H; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):2872-4. PubMed ID: 9365598
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
    Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.